Histopath
Histopath is an Australian pathologist-owned diagnostic laboratory providing histopathology, microbiology, virology, and biochemistry testing to referring doctors, private hospitals, aged care facilities, and NSW Health, supported by integrated digital pathology, AI-assisted cancer detection, and NATA-accredited workflows.
- Company typePrivate
- Founded1998
- HeadquartersSydney, Australia
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Histopath does
Histopath Diagnostic Specialists (trading as Histopath, legal entity Douglas and Mann Pty Ltd) is an Australian pathologist-owned diagnostic laboratory founded in 1998 by Dr Chris Douglas and headquartered in Macquarie Park, NSW. The company provides histopathology, bacteriology, parasitology, virology, and biochemistry testing services to referring doctors — including GPs, surgeons, dermatologists, gastroenterologists, and other specialists — as well as to private hospitals, residential aged care facilities, and disability accommodation providers. Histopath is also the RCPA reference laboratory for parasitology and operates the only Australian histopathology practice of its kind owned and led by pathologists for over 25 years.
The company's technical platform centres on a fully integrated digital pathology workflow (first in Australia to do so), with AI-assisted prostate biopsy evaluation deployed since 2019 and ongoing development of AI for cancer detection and grading across multiple tissue types. Supporting capabilities include 3D image capture technology for surgical specimens (planned for LIMS integration), PCR molecular testing for gastrointestinal pathogens and respiratory viruses including COVID-19, Influenza and RSV, and automated tissue sectioning (first in APAC, introduced 2024). All processes operate within a NATA-accredited laboratory (accredited since 1999, with Digital Pathology NATA Accreditation awarded in 2023) compliant with ISO 15189 (2022) and NPAAC requirements, and are delivered by a team of 20+ specialist FRCPA pathologists.
Histopath generates revenue on a fee-for-service basis per pathology test, with pricing anchored to the AMA Fee Schedule and Medicare rebates available for eligible patients. It operates NO GAP and Bulk Billing rates to ensure patient access, bills private health funds directly for hospital inpatients, and earns government revenue through its NSW Health Local Health Districts partnership for aged care COVID-19 and respiratory testing. Go-to-market is a B2B referral model combining direct enterprise field sales to hospitals and aged care operators, dedicated inside sales and registration flows for individual referrers, and results delivery via a web portal, practice management system integration, PDF, and hardcopy.
Histopath firmographics
Firmographics- Name
- Histopath
- Legal name
- Histopath Diagnostic Specialists (Douglas and Mann Pty Ltd)
- Website
- https://histopath.com.au
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Histopath is an Australian pathologist-owned diagnostic laboratory providing histopathology, microbiology, virology, and biochemistry testing to referring doctors, private hospitals, aged care facilities, and NSW Health, supported by integrated digital pathology, AI-assisted cancer detection, and NATA-accredited workflows.
- Ownership category
- akta.pro rank
Histopath industry classification
Industry- Product category
- Diagnostic Pathology Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)
- akta.pro secondary industries
- Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE), Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays) (HLAAALAI)
Keywords
Where Histopath is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Histopath business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Pathology Testing Services: Fee-for-service pathology testing covering histopathology, microbiology (bacteriology, parasitology), virology, and biochemistry. Services are billed based on AMA Fee Schedule with Medicare rebates available for eligible patients with Medicare or Veterans Affairs cards.
- Bulk Billing and NO GAP Services: The company offers NO GAP and BULK BILLING rates to ensure patient access. For hospital in-patients with eligible Health Fund coverage, they bill health funds directly. This represents a revenue stream from health insurers as well as Medicare rebates.
- Aged Care Facility Testing: Partnership with NSW Health Local Health Districts to provide COVID-19, Influenza and RSV testing for Residential Aged Care Facilities and Disability Accommodation. Revenue generated from government health districts for PCR testing services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Bulk Billing for Eligible Patients |
| Transaction based/ take rate | Pay-as-you-go | NO GAP Billing |
| Unit Pricing | Pay-as-you-go | Faecal Calprotectin Testing |
| Transaction based/ take rate | Pay-as-you-go | Standard Private Billing |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels6 records
Histopath product offering
Product offeringCore offering
Histopath Diagnostic Specialists is a pathologist-owned diagnostic laboratory providing histopathology, microbiology (bacteriology, parasitology, virology), and biochemistry testing services. The company specializes in the examination of tissue biopsies and surgical specimens using fully integrated digital pathology, AI-powered cancer detection and grading, PCR-based molecular testing, and 3D imaging, delivering rapid 24-48 hour turnaround with same-day urgent testing available.
Product overview
Histopath Diagnostic Specialists is a pathologist-owned histopathology and microbiology laboratory offering a comprehensive diagnostic service portfolio. The core offering centers on histopathology (tissue examination) services enhanced by integrated digital pathology and AI capabilities. Supporting services include bacteriology, parasitology, virology, and biochemistry testing for gastrointestinal specimens. The laboratory provides a web-based results portal for referring doctors, with additional services for aged care facilities. All services are delivered with rapid 24-48 hour turnaround through NATA-accredited processes.
Differentiator
Problem solved
Functional benefit
Products and services
- Histopathology Services Examination of tissue biopsies and surgical specimens for referring GPs and specialists. Includes special stains, immunohistochemistry (IHC) for tumour subtyping and molecular marker detection, and intraoperative frozen section examinations during surgery. Used by gastroenterologists, dermatologists, surgeons, urologists, gynaecologists, and other specialists requiring tissue-based diagnosis.
- Bacteriology Services Comprehensive gastrointestinal pathogen testing on faecal specimens and gastric biopsies, including PCR-based detection and clarithromycin antibiotic resistance testing for H. pylori. Designed for GPs and gastroenterologists investigating gastrointestinal infections.
- Parasitology Services RCPA-designated reference laboratory for parasitology identifying protozoa and helminths from faecal specimens using PCR and microscopy, staffed by Australia's most experienced parasitologists. Serves referring doctors and other laboratories requiring specialist parasitology diagnostic support.
- Virology Services Enteric viral panel testing using PCR for norovirus, adenovirus, and rotavirus, plus COVID-19, influenza, and RSV testing for aged care facilities. Targets GPs, gastroenterologists, and aged care/disability accommodation providers requiring rapid infectious disease diagnostics.
- Biochemistry Services
Quantifiable outcome
- 24-48 hour turnaround for routine testing
- +3 more outcomes
Companies that use Histopath
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Histopath technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature7 records
Histopath partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- NSW Health Local Health DistrictscoreHistopath partners with NSW Health Local Health Districts to support Residential Aged Care Facilities and Disability Accommodation with COVID-19, Influenza and RSV testing. The partnership includes a dedicated aged care testing team that manages the referral process, attends facilities for testing, and provides same-day results. This is a government-funded healthcare partnership serving vulnerable populations.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Histopath competitors and assessment
Company assessmentDirect peers
- Australian Clinical Labs: ASX-listed mid-tier Australian pathology operator offering histopathology, microbiology, and molecular diagnostics. Directly comparable in service mix, customer base (referring doctors, hospitals, aged care), and Medicare-bulk-billing revenue model.
- Sullivan Nicolaides Pathology: Sonic Healthcare's Queensland-based flagship pathology subsidiary, one of Australia's largest specialist pathology practices. Competes head-to-head with Histopath on complex histopathology, parasitology, and digital pathology workflows.
- Dorevitch Pathology: Sonic Healthcare's Victoria/New South Wales pathology brand. Direct local competitor in the NSW and Victorian markets for histopathology referrals from GPs, specialists, and hospitals.
- Laverty Pathology: Healius's NSW-focused pathology brand, providing general and specialist pathology services including histopathology. Competes with Histopath for referring doctor share across greater Sydney and regional NSW.
- Melbourne Pathology: Victorian-focused specialist pathology practice offering histopathology, microbiology, and biochemistry services. Comparable to Histopath as a state-level specialist pathology operator with strong referrer relationships.
Broad incumbents
- Sonic Healthcare: Australia's largest pathology operator (and global diagnostics platform) operating Sullivan Nicolaides, Douglass Hanly Moir, Dorevitch, and other regional pathology brands. Overlaps directly with Histopath on histopathology, microbiology, and digital pathology, with vastly greater scale and national coverage.
- Healius Limited: Second-largest Australian pathology network operating Laverty, QML, Dorevitch (NSW/VIC), and other pathology brands. Competes directly with Histopath across histopathology, infectious disease PCR, and bulk-billed GP-referred testing.
Regional players
- Perth Pathology: Western Australia-focused pathology laboratory providing histopathology and general pathology services. Comparable specialist pathology offering but operates in a different Australian geography from Histopath.
Emerging players
- Genomic Diagnostics: Healius subsidiary specialising in molecular and genetic diagnostics for hereditary cancer, reproductive health, and pharmacogenomics. Adjacent to Histopath's immunohistochemistry and PCR-based infectious disease testing, with overlap on biomarker-driven oncology diagnostics.
- 4DMedical: ASX-listed medical imaging AI company developing lung ventilation and perfusion analysis. Adjacent rather than directly competing — both apply AI/ML to clinical diagnostics, but 4DMedical focuses on functional imaging rather than tissue pathology.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Histopath social profiles
Digital presenceHistopath compliance and trust
Trust signalCompliance3 records
Histopath financial estimates
Financial estimateRevenue estimate
Valuation estimate
Histopath leadership team
Management profileNumber of profiles
Profiles3 records
Histopath funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Histopath M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Histopath
What does Histopath do?
Histopath Diagnostic Specialists is a pathologist-owned diagnostic laboratory providing histopathology, microbiology (bacteriology, parasitology, virology), and biochemistry testing services. The company specializes in the examination of tissue biopsies and surgical specimens using fully integrated digital pathology, AI-powered cancer detection and grading, PCR-based molecular testing, and 3D imaging, delivering rapid 24-48 hour turnaround with same-day urgent testing available.
Is Histopath a public or private company?
Histopath is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Histopath founded?
Histopath was founded in 1998. It employs 251 to 500 people.
Where is Histopath based?
Histopath is headquartered in Sydney, Australia, in the Oceania region.
How does Histopath make money?
Three revenue lines are on record. Pathology Testing Services are the primary driver. The others are bulk Billing and NO GAP Services and aged Care Facility Testing.
Who are Histopath's main competitors?
Direct peers on record are Australian Clinical Labs, Sullivan Nicolaides Pathology, Dorevitch Pathology, Laverty Pathology and Melbourne Pathology. Broad incumbents are Sonic Healthcare and Healius Limited. Perth Pathology is listed as a regional player. Emerging players are Genomic Diagnostics and 4DMedical.
Does Histopath have an API?
No public API is recorded for Histopath.
What industry is Histopath in?
Histopath's product category is Diagnostic Pathology Services. Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology), with a secondary code of HLAAALAE, Oncology Diagnostics (tumor profiling, MRD, liquid biopsy). Its NAICS code is 621511 and its SIC code is 8071.